ANN ARBOR, Mich. & CARLSBAD, Calif.—Epigenetics-based research tools company Active Motif Inc. has entered into a technology development partnership with Swift Biosciences, a leader in sample and library preparation for next-generation sequencing (NGS). The two companies have partnered to deliver technical advancements in ChIP-Seq workflow, a foundation application for epigenetics. The samples used in the ChIP-Seq workflow are often challenging because of their limited amounts. Swift Biosciences has developed novel technologies that are said to enable the use of very low input samples and, when combined with Active Motif’s industry leading ChIP-based technologies, the combination provides better sensitivity in detecting key protein-DNA interactions. The resulting combination of technologies is reportedly allowing researchers to use 10 to 100 times less sample, using as little as 10pg of ChIP enriched samples.